Cancer Genetics Inc. (CGIX) Climbed 5.89% or 0.02 To Price $0.28 On Tuesday


Cancer Genetics Inc. (CGIX) climbed 5.89% or 0.02 to $0.28. It is nearly 2.17 million shares traded, which is 140.78% compare to the average total volume 1.54 million. The market cap of CGIX is $15.49 million. The year to date change is 9.89%. The 52 week price range is from $0.2 to $2.2. Price of CGIX have changed 0.42% during last week. It have changed 3.75% over last month, 0.97% over last 3 months, -75.93% over last 6 months and -86.32% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for CGIX is 0.28. The 200-day Moving Averages for CGIX is 0.68. It is 142.86% above current price. The 52-week High is 2.2. It is 685.71% from the current price. The 52-week Low is 0.2. It is -28.57% from current price.

There are some statistics of CGIX. It is has market cap $15.49 million. The share outstanding is 56.28 million. The average volume is 1.54 million. The percent of top 15 Institution holding is 5.40%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of CGIX is -121.38%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of CGIX is -52.23%.


Tags:

Share this post